Back to search
FDAFDA · Food and drugs·Recall number D-1878-2019

Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30

Published October 2, 2019 · Recall initiated: September 17, 2019

Summary

FDA records drug Class II recall D-1878-2019, published October 2, 2019 and initiated September 17, 2019. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 10,543 tubes; Lot: Lot #: 9B21A, Exp. 1/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide within the United States and Puerto Rico
Lot
Lot #: 9B21A, Exp. 1/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-711-30 recalled?

Yes. FDA published recall D-1878-2019 on October 2, 2019. Reported hazard: cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.

What should I do if I have this product?

Voluntary: Firm initiated · Letter